Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

Increasing ICS Compliance: The Voice May Be Recorded, But The Results Are Real
Automated phone calling may help physicians solve a perennial problem: patients who don"t take medicine prescribed for chronic health conditions.
generic viagra
National Vaccine Information Center Questions Safety Of School-Based Swine Flu Vaccine Programs
The National Vaccine Information Center (NVIC) is calling on the Obama Administration and state Governors to provide evidence that it is necessary to give experimental swine flu vaccines to children in schools and that strong mechanisms for vaccine safety screening, recording, monitoring, reporting and vaccine injury compensation are in place. NVIC announced that parental concerns about vaccine safety and vaccine mandates will be addressed Oct. 2-4, 2009 in Washington, D.C. at the Fourth International Public Conference on Vaccination.
Zubni implantati
News of the day
Ever Shorter Hospital Stays After Orthopaedic Operations Present A Major Challenge To Rehabilitation - Pre-operative Training Can Improve Results
"Rehabilitation medicine is facing a major challenge today," says Dr. Karsten Dreinh̦fer (Head of Department for Orthopaedics and Orthopaedic Surgery, Medical Park Berlin Humboldtm̿hle, Germany) speaking at the EFORT Congress in Vienna. "Not only in Germany but in many other European countries too, the trend is towards the shortest possible stay in an acute hospital after orthopaedic or trauma-related surgery. This means patient care is shifting increasingly to the rehabilitation sector, which must then be appropriately equipped and trained." But demographic developments are also presenting a significant challenge to orthopaedic rehabilitation: with modern surgical procedures, surgery such as joint replacement operations can be carried out on more and more patients, including the elderly and the very elderly, who then require special care and mobilization assistance, says Dr. Dreinh̦fer, who has been appointed to the professorship for musculoskeletal rehabilitation, prevention and health care research at the Charit̩ in Berlin. Broad interdisciplinary cooperation is also necessary, he says. "Multimodal concepts have proven to be especially effective in numerous diseases of the musculoskeletal system," says Dr. Dreinh̦fer, speaking of a further important trend. "This involves orthopaedics working together with other disciplines, such as physiotherapy, psychotherapy and sports sciences, to be able to help effectively such common complaints as back pain." He says it is also important to cooperate across various health sectors. "It is increasingly important to optimise, via treatment pathways, the transition from the pre-inpatient sector, to acute care and to rehabilitation."
Diagnostics

FDA Authorizes Emergency Use Of Another Test For 2009 H1N1 Influenza Virus

The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization. The EUA for the Focus Diagnostics Influenza H1N1 (2009) Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) diagnostic test is the third diagnostic test authorized under an EUA by the FDA since the public health emergency involving the 2009 H1N1 influenza virus was declared on April 26, 2009. The EUA allows Focus Diagnostics to distribute the test to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. This test is not typically utilized in a doctor"s office-it is a complex laboratory test performed in an environment that has the necessary equipment. These tests are intended for use in the detection of the 2009 H1N1 influenza virus in patients with symptoms of respiratory infection. "This authorization will contribute to the nation"s capacity for accurate testing for the 2009 H1N1 influenza virus," said Daniel G. Schultz, M.D., director of the FDA"s Center for Devices and Radiological Health. The Focus Diagnostics test amplifies the viral genetic material obtained from swabs of the nose or throat, or from nasal discharges. A positive result indicates that the patient is infected with the 2009 H1N1 influenza virus. However, the test does not indicate the stage of infection. A negative result does not preclude influenza virus infection. The EUA authority allows the FDA, based on the evaluation of available data and other things, to authorize the use of unapproved medical products or unapproved uses of approved medical products following a determination and declaration of emergency. The Focus Diagnostics test is an unapproved device whose use is authorized by the EUA. The authorization ends when the declaration of emergency is terminated or when the FDA revokes the authorization. Emergency Use Authorization is part of Project BioShield, which became law in July 2004. Focus Diagnostics is based in Cypress, Calif. For more information: FDA"s Guidance on Emergency Use Authorization of Medical Products.. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009